Meeting ReportPharmacology

Meeting Report: Targeting the Kinome—20 Years of Tyrosine Kinase Inhibitor Research in Basel

See allHide authors and affiliations

Science's STKE  20 Feb 2007:
Vol. 2007, Issue 374, pp. pe8
DOI: 10.1126/stke.3742007pe8

You are currently viewing the abstract.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

A report on the "Targeting the Kinome" meeting, Basel, Switzerland, 4 to 6 December 2006.


With basic and pharmaceutical researchers, chemists, pharmacologists, and clinicians, the Targeting the Kinome meeting brought together a tremendous group of scientists to discuss the past, present, and future of protein kinase research, with a special emphasis on cancer therapy development. The topics ranged from the kinases themselves as drug targets through the interactions that the actions of these enzymes promote, to the physiological and pathological processes they regulate. Attendees gained insight into drug development, as well as increased understanding of how normal cellular processes are subverted during oncogenesis, which may lead to new targets for intervention.

View Full Text

Stay Connected to Science Signaling